ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,08986
-0,01%
Bitcoin
64.341,67
-0,79%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
20/10/200523h40PR Newswire (US)OLYMPIA registry supports positive safety profile of TAXUS(R) Liberte(TM) stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
20/10/200516h05PR Newswire (US)TAXUS(R) Express(2)(TM) stent system shows significant reduction of restenosis in diabetic patients in clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
19/10/200516h05PR Newswire (US)Angiotech Pharmaceuticals corporate partner Boston Scientific Corporation recognized as leader in development of rigorous clinicNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
19/10/200503h05PR Newswire (US)TAXUS clinical trial data demonstrates outstanding long-term safety & efficacy recordNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/10/200523h05PR Newswire (US)Angiotech Pharmaceuticals Appoints Greg Peet to Board of DirectorsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/10/200516h00PR Newswire (US)Angiotech partner to release long-term clinical trial results on market-leading TAXUS(R) Express(2)(TM) coronary stent system atNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
07/10/200520h52PR Newswire (US)Angiotech completes acquisition of AfmedicaNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/10/200519h58PR Newswire (US)Launch of Zilver(R) PTX(TM) Drug-Eluting Stent WebsiteNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
03/10/200519h00PR Newswire (US)Angiotech Announces Drug Discovery And Development Agreement with CombinatoRxNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/09/200516h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. Named One of Canada's Fastest Growing Technology Companies in 2005 Deloitte Canadian TechnologyNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/09/200516h00PR Newswire (US)Angiotech Announces Positive Adhibit Data to Prevent Surgical AdhesionsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
14/09/200500h10PR Newswire (US)JAMA Article Says TAXUS Stents Half As Likely To Require Reintervention In Complex LesionsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
13/09/200518h00PR Newswire (US)Angiotech announces acquisition of Afmedica, Inc.NASDAQ:ANPI
08/09/200518h18PR Newswire (US)Angiotech partner announces European approval for world's first "next-generation" drug-eluting stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/09/200523h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Thomas Weisel Healthcare ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
16/08/200518h30PR Newswire (US)American Journal of Cardiology Study Finds TAXUS Has Lower MACE Rate Than CypherNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/08/200523h02PR Newswire (US)CABG Medical Announces Device and Clinical Trial Modifications and Second Quarter 2005 ResultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/08/200523h01PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces results for the second quarter ended June 30, 2005NASDAQ:ANPI
03/08/200522h00PR Newswire (US)Decision of European Patent Office to maintain the validity of Angiotech's paclitaxel eluting stent patent (Patent No. 0706376)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/07/200521h00PR Newswire (US)Angiotech to webcast conference call discussing second quarter 2005 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
27/07/200523h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Adams Harkness ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
21/07/200523h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Banc of America ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/07/200521h43PR Newswire (US)Two Patients Treated in First International Case Testing Drug-Eluting Stents To Treat Peripheral Arterial DiseaseNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
20/06/200520h45PR Newswire (US)Angiotech partner completes first enrollment phase in next-generation TAXUS(R) Liberte(TM) coronary stent system registryNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/06/200519h40PR Newswire (US)Updated Time - CURRENTLY IN PROGRESS - Angiotech to host year-in-review presentation from 2005 annual general meeting of sharehoNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
07/06/200523h29PR Newswire (US)Angiotech Pharmaceuticals to participate in Morgan Stanley ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
07/06/200500h06PR Newswire (US)Updated Time - Angiotech to host year-in-review presentation from 2005 annual general meeting of shareholdersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
03/06/200500h06PR Newswire (US)Angiotech to host year-in-review presentation from 2005 annual general meeting of shareholdersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/06/200517h30PR Newswire (US)Angiotech announces formation of a venture initiativeNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/06/200516h01PR Newswire (US)Angiotech licenses ChondroGEL(TM) to Histogenics for use in cartilage and orthopedic tissue regeneration applicationsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
FX
EURGBP
Euro vs Sterling
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
TG
DBK
Deutsche Bank
NASDAQ
NVDA
NVIDIA
TG
RHM
Rheinmetall
DBI
TDXP
Tec DAX
TG
D7G
Nel ASA
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten